title: Reply: To PMID 25434835.
authors: Cooper Medical School at Rowan University, Camden, NJ. Electronic address: cardonick-elyce@cooperhealth.edu.
authors: Elyce
authors: E
authors: Cardonick
authors: Nemours/Alfred I. DuPont Hospital for Children, Wilmington, DE. Electronic address: marcy.gringlas@gmail.com.
authors: Marcy
authors: M
authors: Gringlas
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002657:Child Development; D002658:Developmental Disabilities / Q000453:epidemiology*; D005260:Female; D006801:Humans; D007804:Language Development; D008297:Male; D009048:Motor Skills; D009369:Neoplasms / Q000188:drug therapy*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D047928:Premature Birth / Q000453:epidemiology*; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology*
chemical_list: D000970:Antineoplastic Agents